Page last updated: 2024-11-01

omeprazole and Bewilderment

omeprazole has been researched along with Bewilderment in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fireman, Z1
Kopelman, Y1
Sternberg, A1

Other Studies

1 other study available for omeprazole and Bewilderment

ArticleYear
Central nervous system side effects after proton pump inhibitor treatment.
    Journal of clinical gastroenterology, 1997, Volume: 25, Issue:4

    Topics: Adult; Amnesia; Confusion; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Omeprazole; Proton

1997